Skip to content

APOTHEEK ROOSEN

Active
Private limited companyfounded 1987active for 39 yearsSledderlo 50, 3600 Genk, BelgiumKBO/BCE: BE 0430.444.725

From the official registers: KBO 39 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

APOTHEEK ROOSEN has been active since 1987 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €824,503 and a net result of €111,004. Equity has been growing by about 13% per year since 2018. Its solvency ranks better than 76% of 12,757 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Official details

KBO
Status
Active since 04-02-1987 Normal situation
Activity
Retail sale of pharmaceutical products NACE 47730and 2 others
Establishment unit
2.033.190.175 3600 Genk, since 11-03-1987
Financial year end
31 December
Peppol
Reachable since 26-06-2025

Board and ownership

Board

Financial position

97 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts 2025
Gross margin
€330,099
▼ 6.1%
Turnover
≈ €1.2m
estimated
Profit
€111,004
▼ 21.5%
Equity
€824,503
▲ 15.6%
Total assets
€1.3m
▲ 53.5%
Staff
1.8 FTE
=
Filed on 11-05-2026, 81 days before the deadlinePDF
Score breakdownlowers riskLiquidity: current ratio 5.25, cash €327,661Founded in 1987Size: 1.8 FTE, total assets €1.3mEquity €824,503 (63.4% of total assets)Show the evidence

Checked score

Score 2025
97 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 75% of micro companies in retail trade (NACE 47)
Financial strength · tick: 2024
Strong
Solvency 88-12
equity 63.4% of total assets
Liquidity 80-9
short-term debt 12.1% · cash 25.2%
Profitability 79-11
return on assets 8.5%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,270 companies, NACE 47, micro)
Last 24 months 11-2024: < 0.1% 12-2024: < 0.1%● unchanged vs 11-2024 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025lowest value 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026highest value 07-2026: < 0.1%● unchanged vs 06-2026highest value 08-2026: < 0.1%● unchanged vs 07-2026highest value 09-2026: < 0.1%● unchanged vs 08-2026highest value 10-2026: < 0.1%● unchanged vs 09-2026highest value
Credit of up to €75,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 5.25 (6.06 in 2024), above the usual 1.5. Short-term debt is 12.1% and cash 25.2% of total assets. 36.6% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro). It does better than 76% of them on solvency, 84% on liquidity, 70% on profitability and 68% on growth.

The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskneutral
lowers risk · Liquidity: current ratio 5.25, cash €327,661
NBB · annual accounts
lowers risk · Founded in 1987
Companies that have existed this long fail less often. How much that weighs depends on the rest of the company's profile.
KBO
lowers risk · Size: 1.8 FTE, total assets €1.3m
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
lowers risk · Equity €824,503 (63.4% of total assets)
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 11-05-2026, 81 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
81 days early
2024
57 days early
2023
11 days late
2022
28 days late
2021
3 days early
2020
19 days late
2019
61 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 3 days before the deadline. In the sector (NACE 47), the median for financial year 2024 was on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 28 July (4 of the last 5 accounts filed within 54 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
01-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Positive: More equity than 83% of companies in retail tradesector median €236,771 · 12,767 companies €824,503 View
  • Positive: 8 profitable years in a rowprofit 2025: €111,004 8 years View

Comparable companies

These companies have the same main activity as APOTHEEK ROOSEN: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €1.2m and €1.4m, founded between 1985 and 1990.

CompanyTotal assetsGross margin
APOTHEEK ROOSEN Genk€1.3m€0.3m
LANGENAKEN Bilzen-Hoeselt€1.2m€0.3m
APOTEEK DE FRE Haaltert€1.2m€0.3m
Apothekers MARIABURG Ekeren Antwerpen€1.3m€0.4m
APOTHEEK OOIGEM Wielsbeke€1.4m€0.3m
PHARMACIE HUBERMONT Sainte-Ode€1.3m€0.3m
Apotheek Gorissen Zonhoven€1.3m€0.4m
Full comparison

Documents

Key facts about APOTHEEK ROOSEN

What is the company number of APOTHEEK ROOSEN?
The company number of APOTHEEK ROOSEN is 0430.444.725. The VAT number is the same number with BE in front: BE 0430.444.725.
Where is APOTHEEK ROOSEN based?
The registered office is at Sledderlo 50, 3600 Genk.Company details
What does APOTHEEK ROOSEN do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of APOTHEEK ROOSEN?
The legal form of APOTHEEK ROOSEN is Private limited company (BV).
When was APOTHEEK ROOSEN founded?
APOTHEEK ROOSEN was founded on 04-02-1987.
Is APOTHEEK ROOSEN still active?
Yes, APOTHEEK ROOSEN is an active enterprise in the KBO register.
How many employees does APOTHEEK ROOSEN have?
APOTHEEK ROOSEN had an average of 1.8 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of APOTHEEK ROOSEN?
The turnover in financial year 2025 is ≈ €1.2m. This figure is estimated from the gross margin of €330,099 and 47 comparable companies (NACE 477). It probably lies between €930,000 and €2.0m.
Is APOTHEEK ROOSEN profitable?
In financial year 2025, APOTHEEK ROOSEN made a profit of €111,004.
Where can I find the annual accounts of APOTHEEK ROOSEN?
APOTHEEK ROOSEN filed 39 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts 2025 (PDF)
When are the next annual accounts of APOTHEEK ROOSEN due?
APOTHEEK ROOSEN must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.